Is targeting eNOS a key mechanistic insight of cardiovascular defensive potentials of statins?

P Balakumar, S Kathuria, G Taneja, S Kalra… - Journal of molecular and …, 2012 - Elsevier
Statins are widely used in the treatment of dyslipidemia and associated cardiovascular
abnormalities including atherosclerosis, hypertension and coronary heart disease. Needless …

Statins as regulators of redox state in the vascular endothelium: beyond lipid lowering

M Margaritis, KM Channon… - Antioxidants & redox …, 2014 - liebertpub.com
Significance: Endothelial dysfunction and the imbalance between nitric oxide (NO) and
reactive oxygen species production in the vascular endothelium are important early steps in …

Can modulation of endothelial nitric oxide synthase explain the vasculoprotective actions of statins?

WC Sessa - Trends in molecular medicine, 2001 - cell.com
Statin-based drugs are the mainstay of therapy for coronary artery disease. Recent insights
into the cellular mechanisms of this class of drugs suggest that modulation of nitric oxide …

Beyond lipid-lowering: effects of statins on endothelial nitric oxide

U Laufs - European journal of clinical pharmacology, 2003 - Springer
Endothelial dysfunction is now recognised as an important process in the pathogenesis of
atherosclerosis. Nitric oxide (NO) release by the endothelium regulates blood flow …

[HTML][HTML] Statin-induced nitric oxide signaling: mechanisms and therapeutic implications

AM Gorabi, N Kiaie, S Hajighasemi, M Banach… - Journal of clinical …, 2019 - mdpi.com
In addition to their cholesterol-lowering effects, statins are associated with pleiotropic effects
including improvements in heart failure (HF), reduced blood pressure, prevention of the …

Statins: pleiotropic regulators of cardiovascular redox state

C Antoniades, KM Channon - Antioxidants & redox signaling, 2014 - liebertpub.com
Lipid-lowering treatment with statins is one of the most effective therapeutic strategies in
cardiovascular medicine because they reduce cardiovascular risk in both primary and …

Effects of HMG-CoA reductase inhibitors on endothelial function: role of microdomains and oxidative stress

RP Mason, MF Walter, RF Jacob - Circulation, 2004 - Am Heart Assoc
Certain pleiotropic activities reported for 3-hydroxy-3-methylglutaryl coenzyme A (HMG-
CoA) reductase inhibitors (statins) are related to reductions in cellular cholesterol …

[HTML][HTML] Pleiotropic effects of statins: A boulevard to cardioprotection

A Rohilla, S Rohilla, A Kumar, MU Khan… - Arabian Journal of …, 2016 - Elsevier
Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, referred to as
“statins” have been extensively reported to possess lipid lowering effects by inhibiting the …

Statin mediated protection of the ischemic myocardium

DG Wright, DJ Lefer - Vascular pharmacology, 2005 - Elsevier
Hypercholesterolemia is a major risk factor in the development of cardiovascular disease
and HMG-CoA reductase inhibitors (ie statins) were originally designed to reduce serum …

Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial …

C Antoniades, C Bakogiannis, P Leeson, TJ Guzik… - Circulation, 2011 - Am Heart Assoc
Background—Treatment with statins improves clinical outcome, but the exact mechanisms of
pleiotropic statin effects on vascular function in human atherosclerosis remain unclear. We …